These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12503650)

  • 21. Alpha-interferon in the treatment of subacute sclerosing panencephalitis.
    Fayad MN; Yamout BI; Mroueh S
    J Child Neurol; 1997 Nov; 12(8):486-8. PubMed ID: 9430312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course.
    Tepebaşili I; Caksen H; Odabaş D; Ataş B; Akbayram S
    J Emerg Med; 2004 Apr; 26(3):356-9. PubMed ID: 15028344
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis.
    Tomoda A; Shiraishi S; Hosoya M; Hamada A; Miike T
    Pediatr Neurol; 2001 Jan; 24(1):54-9. PubMed ID: 11182282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraventricular administration of interferon and administration of methisoprinol by mouth in the treatment of adult-onset subacute sclerosing panencephalitis.
    Harbord MG; Jones T; Hicks EP; Blumbergs PC
    Med J Aust; 1988 May; 148(9):467-9, 473. PubMed ID: 2452337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
    Dyken PR; Swift A; DuRant RH
    Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis.
    Gokcil Z; Odabasi Z; Demirkaya S; Eroglu E; Vural O
    J Neurol Sci; 1999 Jan; 162(1):62-4. PubMed ID: 10064170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay.
    Hara S; Kimura H; Hoshino Y; Hayashi N; Negoro T; Okumura A; Kajita Y; Sakuma T; Nakayama T; Hosoya M; Tomoda A; Morisima T
    Brain Dev; 2003 Aug; 25(5):367-9. PubMed ID: 12850518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.
    Anlar B
    Brain Dev; 2004 Aug; 26(5):345; author reply 345-6. PubMed ID: 15165678
    [No Abstract]   [Full Text] [Related]  

  • 29. Improvement of SSPE by intrathecal infusion of alpha-IFN.
    Kurata T; Matsubara E; Yokoyama M; Nagano I; Shoji M; Abe K
    Neurology; 2004 Jul; 63(2):398-9. PubMed ID: 15277654
    [No Abstract]   [Full Text] [Related]  

  • 30. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.
    Hosoya M; Shigeta S; Mori S; Tomoda A; Shiraishi S; Miike T; Suzuki H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):943-5. PubMed ID: 11181386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable outcomes of interferon-α and ribavirin treatment for a male with subacute sclerosing panencephalitis.
    Sonoda Y; Sonoda M; Yonemoto K; Sanefuji M; Taira R; Motomura Y; Ishimura M; Torisu H; Kira R; Kusuhara K; Sakai Y; Ohga S
    J Neuroimmunol; 2021 Sep; 358():577656. PubMed ID: 34304142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man.
    Gagnon A; Bouchard RW
    Arch Neurol; 2003 Aug; 60(8):1160-1. PubMed ID: 12925376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary results for treatments in subacute sclerosing panencephalitis have problems?
    Anlar B
    J Child Neurol; 2004 Jun; 19(6):463; author reply 463-4. PubMed ID: 15446398
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis.
    Aydin OF; Senbil N; Kuyucu N; Gürer YK
    J Child Neurol; 2003 Feb; 18(2):104-8. PubMed ID: 12693776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
    Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
    No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow-up of patients with adult-onset subacute sclerosing panencephalitis.
    Eroglu E; Gokcil Z; Bek S; Ulas UH; Ozdag MF; Odabasi Z
    J Neurol Sci; 2008 Dec; 275(1-2):113-6. PubMed ID: 18783800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute sclerosing panencephalitis: an update.
    Gutierrez J; Issacson RS; Koppel BS
    Dev Med Child Neurol; 2010 Oct; 52(10):901-7. PubMed ID: 20561004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS; Risk WS
    Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of subacute sclerosing panencephalitis: an overview.
    Taylor WJ; DuRant RH; Dyken PR
    Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.
    Tomoda A; Nomura K; Shiraishi S; Hamada A; Ohmura T; Hosoya M; Miike T; Sawaishi Y; Kimura H; Takashima H; Tohda Y; Mori K; Kato Z; Fukushima A; Nishio H; Nezu A; Nihei K
    Brain Dev; 2003 Oct; 25(7):514-7. PubMed ID: 13129596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.